Sharechat Logo

TEM - Market Abuse Regulation, Article 19, Paragraph 11

Wednesday 8th November 2023

Text too small?

In accordance with the Market Abuse Regulation the Company announces that it has today entered into a closed period, which will remain in place until the Company releases its half-yearly results for the period ended 30th September 2023.

 

The Company is satisfied that any inside information which the Directors or the Company may have during the closed period has previously been notified to a Regulated Information Service. The Company is therefore not prohibited from repurchasing its own securities, or issuing new securities, during this closed period.

 

For further information please e-mail temitcosec@franklintempleton.com or contact Client Dealer Services at Franklin Templeton on free phone 0800 305 306, +44 (0) 20 7073 8690 for overseas investors, or e-mail enquiries@franklintempleton.co.uk.

 

7th November 2023

 

END OF ANNOUNCEMENT

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors